1. Kazemian P, Ding DD, Scott JA, Feser MK, et al.
   The cost-effectiveness of a resilience-based psychosocial intervention for HIV prevention among men who have sex with men in India.
   AIDS 2022.
   


2. Tetens MM, Gerstoft J, Kronborg G, Johansen IS, et al.
   Risk of subarachnoid haemorrhages and aneurysms in Danish People Living With HIV, a nationwide cohort study.
   AIDS 2022.
   


3. Aung HL, Gates TM, Mao L, Brew BJ, et al.
   Abnormal cognitive aging in people with HIV: Evidence from Data Integration between two countries' cohort studies.
   AIDS 2022.
   


4. Sax PE, Andreatta K, Molina JM, Daar ES, et al.
   High Efficacy of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with Suppressed HIV and Preexisting M184 V/I.
   AIDS 2022.
   


5. Wong NS, Wong BCK, Chan JMC, Wong KH, et al.
   Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine.
   AIDS 2022.
   


6. Vogt SL, Maloma L, Xian RR, Ambinder RF, et al.
   Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting.
   AIDS 2022.
   


7. Ferguson N, Cogswell A, Barker E.
   Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T-cells During Acute and Chronic SIV Infection of the Colon.
   AIDS Res Hum Retroviruses 2022.
   


8. Narvaez M, Lins-Kusterer L, Valdelamar-Jimenez J, Brites C, et al.
   Quality of life and antiretroviral therapy adherence: A cross-sectional study in Colombia.
   AIDS Res Hum Retroviruses 2022.
   


9. Podell BK, Aibana O, Huang CC, DiLisio JE, et al.
   The Impact of Vitamin A Deficiency on Tuberculosis Progression.
   Clin Infect Dis 2022.
   


10. Young MR, Broadwell C, Kacanek D, Chadwick EG, et al.
    Sexually transmitted infections in pregnant people living with HIV: Temporal trends, demographic correlates and association with preterm birth.
    Clin Infect Dis 2022.
    


11. Seidman D, Logan R, Weber S, Gandhi A, et al.
    Reimagining Preexposure Prophylaxis Provision for Women in the United States.
    Clin Infect Dis 2022.
    


12. Nguyen H, Hampel B, Nunez DG, Battegay M, et al.
    Correction to: Identifying and Characterizing Trans Women in the Swiss HIV Cohort Study as an Epidemiologically Distinct Risk Group.
    Clin Infect Dis 2022.
    


13. Campbell JR, Chan ED, Falzon D, Trajman A, et al.
    Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.
    Clin Infect Dis 2022.
    


14. Garcia-Cremades M, Vucicevic K, Hendrix CW, Jayachandran P, et al.
    Characterizing HIV-preventive, plasma tenofovir concentrations. A pooled participant-level data analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials.
    Clin Infect Dis 2022.
    


15. Cannon CA, Ramchandani MS, Buskin S, Dombrowski J, et al.
    Previous Pre-Exposure Prophylaxis Use Among Men Who Have Sex with Men Newly Diagnosed with HIV Infection in King County, Washington.
    J Acquir Immune Defic Syndr 2022.
    


16. Kwapong YA, Sharma G, Shade JK, Piggott DA, et al.
    Effect of HIV Serostatus on ICU Admission and Mortality among Hospitalized Coronavirus Disease 2019 (COVID-19) Patients.
    J Acquir Immune Defic Syndr 2022.
    


17. Schroter J, Anelone AJN, de Boer RJ.
    Quantification of CD4 Recovery in Early-Treated Infants Living With HIV.
    J Acquir Immune Defic Syndr 2022;89:546-557.
    


18. Zewdie K, Kiptinness C, Ngure K, Kipkurui N, et al.
    Targeted implementation of HIV self-testing increases testing uptake among partners of index persons known to have HIV in Kenya.
    J Acquir Immune Defic Syndr 2022.
    


19. Johnston CD, Siegler EL, Rice MC, Derry-Vick HM, et al.
    Plasma Cell-Free Mitochondrial DNA as a Marker of Geriatric Syndromes in Older Adults with HIV.
    J Acquir Immune Defic Syndr 2022.
    


20. Chaudron SE, Leemann C, Kusejko K, Nguyen H, et al.
    A systematic molecular epidemiology screen reveals numerous HIV-1 superinfections in the Swiss HIV Cohort Study.
    J Infect Dis 2022.
    


21. Petersen KJ, Strain J, Cooley S, Vaida F, et al.
    Machine learning quantifies accelerated white-matter aging in persons with HIV.
    J Infect Dis 2022.
    


22. Li Y, Wang X, Jin J, Ma Z, et al.
    T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    J Med Virol 2022.
    


23. Cieniewicz B, Kirillov V, Daher I, Li X, et al.
    IKKalpha-Mediated Noncanonical NF-kappaB Signaling Is Required To Support Murine Gammaherpesvirus 68 Latency In Vivo.
    J Virol 2022.
    


24. Chikata T, Paes W, Kuse N, Partridge T, et al.
    Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection.
    J Virol 2022.
    


25. Rai M, Timilsina U, Gaur R.
    Construction and characterization of a full-length, replication-competent and infectious enhanced green fluorescence protein-tagged HIV-1 subtype C molecular clone.
    Virology 2022;571:34-38.
    

Display articles in

• Abstract format
• Medline format